Xu L, Sun X, Ma X (2017) Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 16(1):18. https://doi.org/10.1186/s12941-017-0191-3
Article CAS PubMed PubMed Central Google Scholar
Tsuji BT, Pogue JM, Zavascki AP et al (2019) International Consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for anti-infective pharmacology (ISAP), society of critical Care Medicine (SCCM), and Society of Infectious diseases pharmacists (SIDP). Pharmacother J Hum Pharmacol Drug Ther 39(1):10–39. https://doi.org/10.1002/phar.2209
Zeng M, Xia J, Zong Z, Shi Y et al (2023) Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect 56(4):653–671. https://doi.org/10.1016/j.jmii.2023.01.017
Article CAS PubMed Google Scholar
Paul M, Carrara E, Retamar P et al (2022) European Society of Clinical Microbiology and Infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 28(4):521–547. https://doi.org/10.1016/j.cmi.2021.11.025
Article CAS PubMed Google Scholar
Soman R, Bakthavatchalam YD, Nadarajan A et al (2021) Is it time to move away from polymyxins? Evidence and alternatives. Eur J Clin Microbiol Infect Dis 40(3):461–475. https://doi.org/10.1007/s10096-020-04053-w
Article CAS PubMed Google Scholar
Li Z, Cao Y, Yi L, Liu JH, Yang Q (2019) Emergent Polymyxin Resistance: end of an era? Open Forum Infect Dis 6(10):ofz368. https://doi.org/10.1093/ofid/ofz368
Article CAS PubMed PubMed Central Google Scholar
Silva KED, Rossato L, Leite AF, Simionatto S (2022) Overview of polymyxin resistance in Enterobacteriaceae. Rev Soc Bras Med Trop 55:e0349–2021. https://doi.org/10.1590/0037-8682-0349-2021
Article PubMed PubMed Central Google Scholar
Kadri SS, Lai YL, Warner S et al (2021) Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis 21(2):241–251. https://doi.org/10.1016/S1473-3099(20)30477-1
Article CAS PubMed Google Scholar
Nordmann P, Jayol A, Poirel L (2016) Rapid Detection of Polymyxin Resistance in Enterobacteriaceae. Emerg Infect Dis 22(6):1038–1043. https://doi.org/10.3201/eid2206.151840
Article CAS PubMed PubMed Central Google Scholar
Barth PO, Volpato FCZ, Moreira NK, Wink PL, De Souza ÂC, Barth AL (2022) Evaluation of a rapid susceptibility test of polymyxin B by MALDI-TOF. Front Microbiol 13:1075650. https://doi.org/10.3389/fmicb.2022.1075650
Article PubMed PubMed Central Google Scholar
Collar GdaS, Raro OHF, da Silva RMC et al (2021) Polymyxin NP tests (from colonies and directly from blood cultures): accurate and rapid methodologies to detect polymyxin B susceptibility among Enterobacterales. Diagn Microbiol Infect Dis 99(4):115264. https://doi.org/10.1016/j.diagmicrobio.2020.115264
Article CAS PubMed Google Scholar
Fonseca E, Silva D, Silva-Dias A, Gomes R, Martins-Oliveira I, Ramos MH, Rodrigues AG, Cantón R, Pina-Vaz C (2019) Evaluation of rapid colistin susceptibility directly from positive blood cultures using a flow cytometry assay. Int J Antimicrob Agents 54(6):820–823. https://doi.org/10.1016/j.ijantimicag.2019.08.016
Jayol A, Dubois V, Poirel L, Nordmann P (2016) Rapid Detection of Polymyxin-Resistant Enterobacteriaceae from Blood Cultures. Bourbeau P, editor. J Clin Microbiol. 54(9):2273–7. https://doi.org/10.1128/JCM.00918-16
Collar GDS, Moreira NK, Wink PL, Barth AL, Raro OHF, Dias C, De Lima Machado A, Mott MP, Caierão J (2023) Detection of polymyxins resistance among Enterobacterales: evaluation of available methods and proposal of a new rapid and feasible methodology. Ann Clin Microbiol Antimicrob 22(1):71. https://doi.org/10.1186/s12941-023-00618-7
Article CAS PubMed PubMed Central Google Scholar
ISO (2019) ISO 20776-1:2019 susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices – part 1: broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapid. Geneva, Switzerland. https://www.iso.org/standard/70464.html
Barth PO, Roesch EW, Lutz L, De Souza ÂC, Goldani LZ, Pereira DC (2023) Rapid bacterial identification by MALDI-TOF MS directly from blood cultures and rapid susceptibility testing: a simple approach to reduce the turnaround time of blood cultures. Braz J Infect Dis 27(1):102721. https://doi.org/10.1016/j.bjid.2022.102721
Article CAS PubMed Google Scholar
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2024) Methodology - EUCAST rapid antimicrobial susceptibility testing (RAST) directly from blood cultures bottles. https://www.eucast.org/. Accessed 25 March 2024
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2024) Antimicrobial susceptibility testing EUCAST disk diffusion method. https://www.eucast.org/. Accessed 18 March 2024
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2024) Breakpoint tables for interpretation of MICs and zone diameters. https://www.eucast.org/. Accessed 30 January 2024
Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST) (2023) Breakpoint tables for interpretation of MICs and zone diameters. https://www.brcast.org/. Accessed 30 January 2024
Tan X, Kim HS, Baugh K, Huang Y, Kadiyala N, Wences M, Singh N, Wenzler E, Bulman ZP (2021) Therapeutic options for Metallo-β-Lactamase-Producing Enterobacterales. Infect Drug Resist Volume 14:125–142. https://doi.org/10.2147/IDR.S246174
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2016) Recommendations for MIC determination of colistin (polymyxin E) As recommended by the joint CLSI-EUCAST Polymyxin Breakpoints Working Group, https://www.eucast.org. Accessed 15 February 2024
Wink PL, Martins AS, Inamine E, Dalmolin TV, Barth AL (2019) Rapid detection of the main carbapenemases in Brazil directly from spiked blood culture using the RESIST-3 O.K.N. immunoassay. Braz J Microbiol 50(3):657–662. https://doi.org/10.1007/s42770-019-00109-y
Article CAS PubMed PubMed Central Google Scholar
Malli E, Papagiannitsis CC, Xitsas S, Tsilipounidaki K, Petinaki E (2019) Implementation of the Rapid Polymyxin™ NP test directly to positive blood cultures bottles. Diagn Microbiol Infect Dis 95(4):114889. https://doi.org/10.1016/j.diagmicrobio.2019.114889
Article CAS PubMed Google Scholar
Luo Q, Xu L, Wang Y, Fu H, Xiao T, Yu W, Zhou W, Zhang K, Shen J, Ji J, Ying C, Xiao Y (2024) Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: a genomic, retrospective cohort study. Clin Microbiol Infect S1198743X:24000363. https://doi.org/10.1016/j.cmi.2024.01.014
Food and Drug Administration (FDA) (2018) Antimicrobial Susceptibility Test (AST) Systems - Class II Special Controls Guidance for Industry and FDA, https://www.fda.gov. Accessed 20 February 2024
Zayet S, Lang S, Garnier P, Pierron A, Plantin J, Toko L, Royer PY, Villemain M, Klopfenstein T, Gendrin V (2021) Leclercia adecarboxylata as Emerging Pathogen in Human infections: clinical features and Antimicrobial susceptibility testing. Pathogens 10(11):1399. https://doi.org/10.3390/pathogens10111399
Comments (0)